reported that a trimer-mimetic TRAIL on a nanocage exhibits superior binding affinity toward DR5 and anti-tumor efficacy compared with monomeric TRAIL, but no data around in vivo stability were not shown70. The gene discussed is TNFRSF10B; the disease is neoplasm.